 |
Recombinant human monoclonal antibody against human complement component C5a |
|---|---|
| Trade Name | |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2016-10-06 00:00:00 |
| Sponsor | Alexion Pharmaceuticals, Inc.;100 College Street;New Haven, Connecticut, 06510 |
